Ingenix, a health information, technology, consulting and services company, announced that it has expanded its health outcomes measurement capabilities with the acquisition of QualityMetric Incorporated. QualityMetric helps health care companies assess health outcomes as reported by patients themselves, known as patient-reported outcomes.
This acquisition adds a new dimension to the capabilities Ingenix can offer to life sciences companies, governments, health systems, payers and consumers. Patient-reported outcomes (PROs) are an important measure of the ultimate effectiveness of health care. QualityMetric develops and maintains popular general and disease-specific health surveys for measuring patients’ own assessments of their health.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FSP Outsourcing in Clinical Research: Trends and Opportunities
June 9th 2025When drug developers choose the right outsourcing strategies in clinical research, they can gain significant benefits in terms of quality, efficiency, and operational success. In its third annual Functional Service Provider (FSP) Trends Report, Thermo Fisher Scientific’s clinical research business—PPD—gathered insights from 150 global biotech and pharma leaders to determine how FSP models help sponsors address common industry obstacles.